More on IBRX

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (10.0 Score)

Upcoming Events

- Earnings (8/5/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

ImmunityBio (NQ:IBRX)
Delayed: 8.67 -0.29 (3.24%)
Prev. Close $8.96  
Open$8.78 
52 Wk High$ 
52 Wk Low$ 
Day High$9.12 
Day Low$8.50 
P/E N/A  
EPS$ 
Volume23,000,564 

Friends, Peers and Foes (?): ALNY, ARVN, ARWR, CAPR, CRDF (more...)

Mar 4, 2026 07:54 AM Immunitybio Inc (IBRX) PT Raised to $12 at Piper Sandler
Feb 27, 2026 07:30 AM ImmunityBio to Provide a Business Update and Review Financial Results for FY 2025 on Tuesday, March 3, 2026
Feb 26, 2026 08:12 PM Form 4 ImmunityBio, Inc. For: Feb 24 Filed by: Simon Barry J.
Feb 26, 2026 07:31 AM ImmunityBio completes enrollment in bladder cancer trial ahead of schedule
Feb 26, 2026 07:30 AM ImmunityBio Completes Enrollment in Pivotal Randomized Trial Evaluating ANKTIVA® Plus BCG Versus BCG Alone in BCG-Naïve Non-Muscle Invasive Bladder Cancer Carcinoma In Situ
Feb 25, 2026 09:52 PM Form SCHEDULE 13D/A ImmunityBio, Inc. Filed by: Cambridge Equities, LP
Feb 25, 2026 03:09 PM ImmunityBio (IBRX) January 5.5 puts active as share price down 14.5%
Feb 24, 2026 08:06 PM Form 4 ImmunityBio, Inc. For: Feb 23 Filed by: Selecky Christobel
Feb 24, 2026 08:05 PM Form 4 ImmunityBio, Inc. For: Feb 22 Filed by: Sachs David C.
Feb 24, 2026 08:05 PM Form 4 ImmunityBio, Inc. For: Feb 22 Filed by: SOON-SHIONG PATRICK
View All Articles

Entities mentioned with IBRX

View All Entities